TAZORAC SUMMARY
TAZORAC® Gel is a translucent, aqueous gel
and contains the compound tazarotene, a member of the acetylenic class of
retinoids. It is for topical dermatologic use only.
TAZORAC® (tazarotene) Gel 0.05% and 0.1%
are indicated for the topical treatment of patients with stable plaque psoriasis
of up to 20% body surface area involvement.
TAZORAC® (tazarotene) Gel 0.1% is also indicated for
the topical treatment of patients with facial acne vulgaris of mild to moderate
severity.
The efficacy of TAZORAC® Gel in the treatment of acne
previously treated with other retinoids or resistant to oral antibiotics has not
been established.
|
|
NEWS HIGHLIGHTS
Published Studies Related to Tazorac (Tazarotene Cutaneous)
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris. [2010.05] This 16-week study evaluated once-daily tazarotene 0.1% cream and adapalene 0.3% gel in patients with moderate-to-severe acne. Patients treated with tazarotene 0.1% cream performed better in many acne efficacy measures (reduction in lesion counts, percentage of patients achieving a 50 percent lesion count reduction, overall disease severity, investigator's global assessment) than did patients treated with adapalene 0.3% gel...
Comparative efficacy and safety results of two topical combination acne regimens. [2009.07] Combination therapy has become the standard for the management of acne, particularly for moderate-to-severe cases... Both treatment regimens were well-tolerated.
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. [2007.12.01] PURPOSE: To evaluate the ability of either oral minocycline, topical tazarotene or both, to reduce or prevent cetuximab-related acneiform rash when administered starting on day 1 of cetuximab therapy... CONCLUSION: Prophylaxis with oral minocycline may be useful in decreasing the severity of the acneiform rash during the first month of cetuximab treatment. Topical tazarotene is not recommended for management of cetuximab-related rash.
Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin. [2007.06] BACKGROUND: Topical retinoids, including adapalene and tazarotene, are a primary treatment choice for patients with acne. Adapalene is currently marketed in a 0.1% concentration in gel and cream formulation. A new gel containing a higher concentration (0.3%) of adapalene has been developed. In clinical studies, adapalene 0.1% concentration has proven to be better tolerated than other retinoids in skin treatment. However, the tolerability of adapalene gel 0.3% has yet to be compared to other topical retinoids. PURPOSE: The purpose of this study was to compare the local cutaneous tolerability of adapalene gel 0.3% once daily versus tazarotene cream 0.05% once daily... CONCLUSION: Adapalene gel 0.3% is very well-tolerated with good cosmetic acceptability.
Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study. [2007.01] BACKGROUND: No controlled data is available till date comparing topical tazarotene and clobetasol in Indian psoriatic patients. OBJECTIVE: The aim was to compare the clinical efficacy of 12 weeks of once-daily tazarotene 0.1% cream with that of once-daily clobetasol propionate 0.05% cream in the treatment of patients with chronic plaque psoriasis... CONCLUSION: Topical tazarotene 0.1% cream is less effective than topical clobetasol propionate 0.05% cream in the treatment of plaque psoriasis. It has more effect on induration than on erythema and scaling of psoriatic lesions.
Clinical Trials Related to Tazorac (Tazarotene Cutaneous)
A Study Comparing Tazarotene Cream 0.1% to Tazorac� and Both to a Placebo Control in the Treatment of Acne Vulgaris [Completed]
Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis [Recruiting]
Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris [Completed]
This is a safety, tolerability and pharmacokinetics study of AGN-190168 in subjects with
acne vulgaris.
Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris [Not yet recruiting]
The primary objective of this study is to compare the safety and efficacy of once daily
application of IDP-123 Lotion to Tazorac Cream, 0. 1%, Vehicle Lotion, and Vehicle Cream in
subjects with moderate to severe acne vulgaris.
Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails [Completed]
The purpose of this study is to determine whether topical tazarotene (Tazorac), a
receptor-selective synthetic retinoid that normalizes epidermal differentiation, ameliorates
signs and symptoms of brittle nails.
Reports of Suspected Tazorac (Tazarotene Cutaneous) Side Effects
Pregnancy (12),
Erythema (6),
Skin Exfoliation (5),
Pruritus (3),
Pain (3),
Skin Burning Sensation (3),
Burning Sensation (3),
Drug Ineffective (2),
Skin Hyperpigmentation (2),
Application Site Erythema (2), more >>
|
PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 25 ratings/reviews, Tazorac has an overall score of 7.20. The effectiveness score is 7.44 and the side effect score is 6.64. The scores are on ten point scale: 10 - best, 1 - worst. Below are selected reviews: the highest, the median and the lowest rated.
| Tazorac review by 42 year old female patient | | Rating |
Overall rating: | |           |
Effectiveness: | | Highly Effective |
Side effects: | | Mild Side Effects | | Treatment Info |
Condition / reason: | | Adult onset acne |
Dosage & duration: | | To use at night on lesions (dosage frequency: once a day) for the period of Used for 3 months |
Other conditions: | | Menopause |
Other drugs taken: | | N/A | | Reported Results |
Benefits: | | The drug cleared the acne. In addition, it peeled away old skin at the site. I used it over small wrinkles and skin lines (without doctor's knowledge). I was pleased with the results over small skin lines. These dissapeared or diminished. The product does not work over face parenthesis or deep wrinkles. It appeared to me that skin's tone also improved. The skin also developed a healthy shine. |
Side effects: | | The side effects as reported are skin redness and sun sensitivity. I experienced both. Always use this product with a sun screen or you will burn 10X faster. The product should be used as directed and a little goes a long ways. I used too much at the beggining (I also left on the product during the day) and my skin got really irritated and peeled. |
Comments: | | The product was to be used at bedtime. To leave on all night and wash in the morning. The treatment was to continue until acne resolved then use as needed. |
|
| Tazorac review by 56 year old female patient | | Rating |
Overall rating: | |           |
Effectiveness: | | Moderately Effective |
Side effects: | | Moderate Side Effects | | Treatment Info |
Condition / reason: | | wrinkles,uneven skin tone,large pores |
Dosage & duration: | | 0.1% cream (dosage frequency: 1x per day) for the period of 3 months |
Other conditions: | | none |
Other drugs taken: | | topical hydroquinone4% | | Reported Results |
Benefits: | | There was a noticable smoothing of the skin and lightening of age spots. |
Side effects: | | Slight peeling of the skin occurred as did some redness and dryness. I added additional moisturizer to alleviate dryness |
Comments: | | Used tazorac cream 01% in conjunction with Obagi Nu- Derm system. Applied it after mixing a small amount with Obagi Blender with hydroquinone after cleansing skin. Used Obagi Clear and Exfoderm and sunscreen during the daytime. |
|
| Tazorac review by 36 year old female patient | | Rating |
Overall rating: | |           |
Effectiveness: | | Moderately Effective |
Side effects: | | Mild Side Effects | | Treatment Info |
Condition / reason: | | Hyperpigmentation, light breakouts, fine lines |
Dosage & duration: | | pea size spread over face nightly (dosage frequency: nightly) for the period of 6 months |
Other conditions: | | Rheumatoid Arthritis |
Other drugs taken: | | Methotrexate | | Reported Results |
Benefits: | | There was very minimal difference in lines- no noticable change in the melasma. I beleive I am taking the lowest dose and may have benefitted from switching to the more potent formula. I was cautious to do so as I was advised there may be considerable redness & peeling. |
Side effects: | | Peeling skin, redness
Other than sperficial side effects, I did not notice anything else, nothing too uncomfortable. My skin seemes a little bit drier, which is why it was peeling.. I suppose that is how the pharmaceutical company thinks it will help with the fine lines by peeling off layers of skin |
Comments: | | Nightly application OVER moisturizer to help correct melasma(Age spots, hyperpigmentation)and fine lines as well as reduce acne breakouts. I tried this for the last 6 months after hearing such great feedback from people who tried it.. I had used Retin A previously and did not see any improvement with that. |
|
|
Page last updated: 2010-10-05
|